Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.5899
Delayed Data
As of 3:59pm ET
 +0.0093 / +1.60%
Today’s Change
0.39
Today|||52-Week Range
4.24
-80.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2009
Quarter 3
2009
Quarter 4
2009
Quarter 2
2016
Revenue and IncomeOther Operating Income--19.2K----
 
 
Net Revenues0.0019.2K0.0036.7M
 
 
 
Cost of Goods Sold0.00103.0K0.0012.2M
 
 
 
Depreciation And Amortization894.00894.00930.0021.1M
 
 
 
 
 
 
Operating ExpensesGross Income-894.00-84.7K-930.003.5M
 
 
 
 
 
General Expenses------28.0M
 
 
Other Operating Expenses338.9K298.1K577.8K0.00
 
 
 
 
Research And Development------2.5M
 
 
Total Operating Expenses339.8K402.0K578.8K61.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-339.8K-382.8K-578.8K-24.5M
 
 
 
 
 
Extraordinary Credit0.000.000.004.1M
 
 
Extraordinary Charge0.000.00-80.0K0.00
 
 
Interest Expense On Debt0.000.002.4K8.9M
 
 
 
Interest Expense Total----2.4K--
 
 
Other Expenses21.3K0.00181.0K-1.8M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-318.5K-382.8K-480.1K-31.1M
 
 
 
 
 
Income Taxes0.000.000.00-10.0K
 
 
Net Income-318.5K-382.8K-480.1K-31.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.7M3.7M3.7M66.7M
 
 
 
 
 
Shares To Calculate EPS Diluted3.7M3.7M3.7M66.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.10-$0.12-$0.47
 
 
 
 
 
EPS Diluted-$0.08-$0.10-$0.12-$0.47